Fibrocell to Present at Phacilitate Cell and Gene Therapy World 2018 – Nasdaq
|
Fibrocell to Present at Phacilitate Cell and Gene Therapy World 2018
Nasdaq EXTON, Pa., Jan. 24, 2018 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that John Maslowski … |
